We have read with interest the paper of Dechering et al. [1] on the reproducibility of the AASI in the hypertensive recently published in this journal. This study of reproducibility for a new index was needed and supports the data from two of our studies [2, 3] indicating a rather modest reproducibility. We are not sure why the authors claim it to be the first study of reproducibility as they cite ours in the discussion. Nonetheless, the main point is that despite studying different populations with different mean values of AASI at different times between the two examinations and using different equipment, their results were comparable to ours.
Our first study [2] was on a small sample of 38 patients with two examinations a fortnight apart. The standard deviation (SD) of the differences between the two measurements was 0.15, which is comparable to the values of 0.16 and 0.20 in the two populations studied by Dechering. From the SD of the differences (SDD) in our report the repeatability coefficient is readily calculated to be 0.30, versus 0.32-0.40 for the study of Dechering. Interestingly, our results show a rather better reproducibility for the AASI than that observed by Dechering. The authors suggest expressing this coefficient as a percentage of the maximal biological variation of the measurement in the studied population, estimated by multiplying the SD of the mean of the measurements on the two occasions by four. They suppose in the discussion that this calculation might alter the results of our comparison of the AASI with the QKD 100-60 . This method of expression seems debatable as the poorer the reproducibility of a parameter the greater will be the SD of the measurement, tending to reduce this percentage value. Furthermore, although the significance of the repeatability coefficient is clear [4] , assigning a rapid confidence interval to the measured value, its expression relative to the 'biological' variability of the measurement has no directly useful significance. Nevertheless, we calculated this percentage as described and found 34% for the QKD 100-60 and 58% for the AASI, which still favors the better reproducibility of the QKD 100-60 by almost a factor of two.
We found similar results in the PROOF [3] cohort, which included individuals from the general population all aged 65 years on recruitment. These individuals benefited from a second recording 2 years later. Here again the SD of the differences of the QKD 100-60 and AASI appeared relatively constant, although arterial stiffness may well have altered over 2 years. The normotensive individuals had a significant fall (P ¼ 0.02) in QKD 100-60 as expected from normal aging, whereas the AASI was unchanged. Table 1 [5, 6] summarizes these data including those of Dechering for the sake of comparison. We have also included the results of two other studies for which the reproducibility values for QKD 100-60 were available.
We maintain that the QKD 100-60 has better reproducibility than the AASI, and in turn a higher sensitivity in the search for alterations in arterial rigidity with time or under treatment. We would first like to clarify that when we submitted our manuscript [1] , Gosse et al. [2] had only published the report on the prediction of cardiovascular complications by the QRS Korotkoff Delay index standardised to a systolic blood pressure of 100 mmHg and a heart rate of 60 bpm (QKD 100-60 ). Gosse et al. [2] also studied the short-term (2 weeks) reproducibility of QKD 100-60 and the ambulatory arterial stiffness index (AASI) in 38 volunteers who were selected from a cohort of 469 hypertensive patients. In a subsequent article [3] , published after ours had been accepted for publication [1] , the French researchers investigated the long-term (2 years) reproducibility of QKD 100-60 and AASI in a 65-year birth cohort recruited from the municipality Saint Etienne.
We are grateful to the French investigators because they followed our suggestion [1] to express repeatability (twice the standard deviation of the differences between duplicate recordings) as a percentage of nearly maximal variation in the measurement under study (four times the standard deviation). In the PROOF study [3] , QKD 100-60 ranged from 160 to 280 ms and AASI ranged from 0.27 to 0.97. From the lowest to the highest value, QKD 100-60 increased by 1.8-fold and AASI by 3.6-fold. In contrast to the statement of Gosse et al. [2] , expressing repeatability as a percentage of nearly maximal variation is not debatable, but the only possible way to compare repeatability among AASI, Ambulatory Arterial Stiffness Index; CV, coefficient of variation; interval, time between first and repeat measurement; HT, hypertensive; NT, normotensive; pMV, RC expressed as a percentage of four times the SD of the mean of the paired recordings; Pts, patients studied; RC, repeatability coefficient; SDD, standard deviation of differences; SS, patients with systemic sclerosis.
measures of a similar trait that are expressed in different units and/or have a dissimilar range [4] .
Gosse et al. [2] claim that QKD 100-60 has higher reproducibility than AASI. However, the table in the letter by Gosse et al. [2] does not include any test statistic or associated P-value to substantiate this assertion. The French report only involved 65-year-old patients, whereas, in our study [1] , the age range was 20-78 years. Moreover, Gosse et al. [2] overlooked that they had standardized QKD 100-60 to a systolic blood pressure of 100 mmHg and a heart rate of 60 bpm, whereas we did not standardize AASI for any of these factors. A selected age group and standardizing QKD 100-60 removes variability in the measurement, which might increase reproducibility, but at the expense of removing potentially relevant information.
We doubt that 38 patients, selected by unspecified criteria, are sufficient to compare the short-term variability of QKD 100-60 and AASI in a reliable fashion [2] . In the report on the long-term reproducibility [3] , over a 2-year interval, a significant reduction occurred in QKD 100-60 in 237 normotensive subjects (À2 ms; P ¼ 0.02), but not in 75 hypertensive patients (þ1 ms). AASI did not change in 568 normotensive subjects (þ0.01) or in 211 hypertensive patients (À0.01). The 2 ms reduction in QKD 100-60 in normotensive subjects is counterintuitive because hypertension, not normotension, accelerates arterial stiffening with age. The physiological meaning of a 2 ms change remains obscure, because the standard deviation of the differences between paired recordings was as high as 9 ms. The number of patients available for analysis of the repeatability of QKD 100-60 (n ¼ 312) and AASI (n ¼ 779) also highlights the technical difficulties in obtaining high-quality estimates of QKD 100-60 , whereas AASI can be computed from simple 24 h ambulatory blood pressure recordings without the discomfort for patients of wearing ECG electrodes.
Finally, Gosse et al. [2] argued that QKD 100-60 reflected arterial stiffness better than AASI because, in multivariable-adjusted analyses, QKD 100-60 correlated with pulse pressure and the presence of diabetes mellitus, whereas AASI only correlated with blood pressure. We believe that prognostic value prevails over statistical findings. To date, several cross-sectional studies [5, 6] and at least four prospective cohort studies [7] [8] [9] [10] demonstrated an association of AASI with all-cause mortality in patients referred for ambulatory blood pressure monitoring [10] or with cardiovascular mortality and morbidity in hypertensive patients [7] , or in the general population [8, 9] . When adjusted for pulse pressure [7] [8] [9] or aortic pulse wave velocity [11] , AASI remained predictive, in particular of stroke. To our knowledge, the corresponding prognostic information for QKD 100-60 rests on a single underpowered study [2] .
